Technology in assisted reproduction has come a long way since the first successful live birth from IVF nearly 3 decades ago. While reproductive endocrinology and infertility is a young field, the technology in this area of medicine has evolved rapidly and have occurred in all phases of care. Clinically, we have developed better methods of IVF monitoring, body mass assessment, and explored the impact of the microbiome, the patient’s diet, and their genetic make-up. In the embryology laboratory we have seen technologic development that improves embryo culture, minimizes variation, and circumvents road blocks set forth by the pathologies discovered.
The assessment of embryos utilizing new technologies which study DNA, RNA, protein, and epigenetics have allowed for a much better understanding of embryo development. These discoveries have opened up a host of new questions that must be answered.